Comparison of the effect of Cichorium intybus and N-acetylcysteine versus placebo on the reduction of liver complications of Fingolimod in patients with multiple sclerosis
Phase 3
Recruiting
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT20120215009014N410
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 63
Inclusion Criteria
Age 18 to 65 years;
Multiple sclerosis;
At least 3 weeks after receiving corticosteroids;
Exclusion Criteria
Pregnancy and lactation;
History of tuberculosis, AIDS, hepatitis, diabetes, kidney failure, or hypertension
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of liver enzyme (ALT, AST, and bilirubin). Timepoint: 2 and 4 months after the intervention. Method of measurement: through laboratory test.
- Secondary Outcome Measures
Name Time Method